Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$26.64 0.06 | 0.23%
09/28/16 - 09:36 AM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:51.72
Price Earnings Comparisons:
SUPNSector Avg.S&P 500
51.725512.9
Price Performance History (% change):
3 Mo1 Yr3 Yr
47.257660.4104256.7785
GROWTH12 Mo3 YrCAGR
Revenue18.396.63.53
Net Income-29.5-1.30
EPS-12.5-1.1n/a
Earnings for SUPN:
EBITDA19.33M
REVENUE144.43M
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.20 $0.21 $0.68 $1.37
Number of Analysts 5 5 6 6
High Estimate $0.23 $0.28 $0.75 $1.65
Low Estimate $0.19 $0.16 $0.55 $1.01
Prior Year $0.08 $0.14 $0.31 $0.68
Growth Rate (Year over Year) 155.00% 50.00% 119.89% 100.73%

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter